Hexvix 85 mg polvere e solvente per soluzione endovescicale

DRUG2 trials

Sponsors

Universita' Degli Studi Di Roma La Sapienza, Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino

Conditions

Non-muscle invasive bladder cancer (NMIBC)Not muscular invasive bladder cancer

Phase 4

Non-inferiority, Phase IV, Open-label, Randomized Controlled Trial of primary Photodynamic Trans-urethral Resection of Bladder Tumors (PDD-TURBT) versus conventional white-light TURBT plus Repeated-TURBT (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) candidate for second look and resection

RecruitingCTIS2023-507307-64-00

Universita' Degli Studi Di Roma La SapienzaNon-muscle invasive bladder cancer (NMIBC)

Start: 2025-12-22Target: 258Updated: 2024-02-20

The impact of PDD during TURB for NMIBC: a prospective randomized controlled trial

Not yet recruitingCTIS2024-514316-27-00

Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di TorinoNot muscular invasive bladder cancer

Target: 300Updated: 2025-05-19

Related Papers

VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐ <i>less</i> ’ Randomised Trial Protocol

British Journal of Urology2024-10-132 citations